Question 1:
What is the frequency of smoking habits of the LC patients  based on their genetic mutations (biomarkers)?

Question 2:
What is the frequency of age categories of the LC patients based on their genders?

Question 3:
What is the frequency of the genetic mutations (biomarkers) of the LC patients based on their age category, smoking habits and genders?

Question 4:
What is the frequency of the smoking habits and age category of the LC patients who receive or not the drug Nivolumab?

Question 5:
What is the frequency of the LC patients who receive or not the drug Nivolumab according to their smoking habits and age category? 
